KEGG   PATHWAY: mcoc05213
Entry
mcoc05213                   Pathway                                
Name
Endometrial cancer - Mastomys coucha (southern multimammate mouse)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
mcoc05213  Endometrial cancer
mcoc05213

Disease
H00026  Endometrial cancer
Organism
Mastomys coucha (southern multimammate mouse) [GN:mcoc]
Gene
116069491  Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
116070104  Cdh1; cadherin-1 [KO:K05689]
116071392  Egfr; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
116072734  Mlh1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
116073648  Mapk6; mitogen-activated protein kinase 6 [KO:K04371] [EC:2.7.11.24]
116073724  Ctnnb1; catenin beta-1 [KO:K02105]
116073764  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
116073820  Araf; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
116073929  Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
116073994  Elk1; ETS domain-containing protein Elk-1 [KO:K04375]
116074727  Ctnna3; catenin alpha-3 isoform X1 [KO:K05691]
116075029  Bak1; bcl-2 homologous antagonist/killer [KO:K14021]
116075178  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
116075286  Foxo3; forkhead box protein O3 [KO:K09408]
116075850  Apc2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
116075868  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
116076013  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
116076684  Axin1; axin-1 isoform X1 [KO:K02157]
116076714  Axin2; axin-2 [KO:K04385]
116076719  Grb2; growth factor receptor-bound protein 2 [KO:K04364]
116077116  Tp53; cellular tumor antigen p53 isoform X1 [KO:K04451]
116077224  Tcf7; transcription factor 7 isoform X1 [KO:K02620]
116077605  Erbb2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
116078189  Pdpk1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
116079779  Akt1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
116080813  Sos1; son of sevenless homolog 1 [KO:K03099]
116080934  Sos2; son of sevenless homolog 2 isoform X1 [KO:K03099]
116081743  Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
116082253  Myc; myc proto-oncogene protein [KO:K04377]
116083555  Polk; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
116083721  Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
116085641  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
116085894  Gsk3b; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
116086966  Apc; adenomatous polyposis coli protein isoform X1 [KO:K02085]
116086989  Ctnna1; catenin alpha-1 [KO:K05691]
116090466  Ddb2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
116093530  Nras; GTPase NRas [KO:K07828]
116093773  Egf; pro-epidermal growth factor [KO:K04357]
116093789  Lef1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
116095058  Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
116096465  Pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
116096967  Casp9; caspase-9 [KO:K04399] [EC:3.4.22.62]
116097037  Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
116098774  Braf; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
116099018  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
116099088  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
116099100  Ctnna2; catenin alpha-2 isoform X1 [KO:K05691]
116099433  Raf1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
116099791  Kras; GTPase KRas isoform X1 [KO:K07827]
116101889  Akt2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
116102201  Bax; apoptosis regulator BAX isoform X1 [KO:K02159]
116102736  Ilk; integrin-linked protein kinase [KO:K06272] [EC:2.7.11.1]
116102969  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
116103285  Ccnd1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
116103467  Bad; bcl2-associated agonist of cell death isoform X1 [KO:K02158]
116103746  Pten; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
116104020  Tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
116104026  Akt3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
mcoc04010  MAPK signaling pathway
mcoc04012  ErbB signaling pathway
mcoc04060  Cytokine-cytokine receptor interaction
mcoc04110  Cell cycle
mcoc04115  p53 signaling pathway
mcoc04151  PI3K-Akt signaling pathway
mcoc04310  Wnt signaling pathway
mcoc04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system